Why Do Non-Fasting Blood Tests Lift Benefit Utilization Rates?
Non-fasting blood tests lift benefit utilization rates because they delete the three costs that stop healthy people from booking a screening test — a preventive check for a symptom-free person that flags areas worth monitoring before problems surface. Those costs are the lost workday, the overnight fast, and the fear of a vein puncture. When a screening requires no fasting and uses capillary blood — 9 to 10 drops taken from a finger prick rather than from a vein — the employee no longer has to plan around it, and a benefit that was previously "worth doing someday" becomes something they do this morning at their desk. MP Check delivers exactly this: clinical, Sheba-validated screening at the home or the office, with no fasting and no needle in the arm, and with most results interpreted on the spot in a summary conversation with a specialist physician. Because the panel is assembled from a short questionnaire, each participant receives only the checks relevant to them, so the session fits between meetings rather than replacing a morning. Insured members may also be eligible for reimbursement of up to 80% under periodic testing or preventive medicine coverage, which removes the cost objection alongside the logistical one.
Why does the fasting requirement suppress preventive benefit utilization rates?
A fasting requirement suppresses preventive benefit utilization because it turns a simple screening test — a preventive check on a healthy person that flags areas worth monitoring before symptoms appear — into a scheduling problem the employee must solve days in advance. The blood draw itself is brief; the overnight fast, the early-morning slot, the traffic, and the missing breakfast are what people actually decline.
What are the attributes of a fasting protocol that drive drop-off?
| Attribute | Typical value or range | Why it depresses participation |
|---|---|---|
| Fast duration | Overnight, from the prior evening until the draw | Locks the appointment into a narrow early-morning window with no flexibility |
| Appointment window | Morning only, weekdays | Collides with school runs, shift starts, and standing meetings |
| Location | Hospital or clinic lab, off-site | Adds travel, parking, and queueing to an already unfed morning |
| Sample method | Venous draw with a needle | Deters anyone with needle anxiety, independent of the fast |
| Result turnaround | Reported back later, after lab processing | Removes the immediate payoff, so the effort feels unrewarded |
| Rescheduling cost | Full restart of the fast | One missed slot often ends the attempt entirely |
Each attribute compounds the previous one. An employee who breaks the fast with morning coffee cannot simply arrive later — the whole cycle restarts, and a benefit that requires two attempts frequently gets none.
MP Check removes the fasting gate at the root: screening runs on capillary blood, a small sample taken from a finger prick rather than a vein, with no fast beforehand and no needle. That changes what HR is actually asking of people — a short visit at the desk instead of a lost morning. The kit is mobile and deployed nationally, so regional offices and peripheral sites get the same protocol as headquarters, and the questionnaire-based panel keeps each session focused on the checks that participant actually needs.
What exactly is a non-fasting blood test, and which panels qualify?
This depends on what you mean by "non-fasting" — the term carries two distinct meanings that are worth separating before anyone designs a screening benefit around it.
Interpretation 1: no food restriction before the draw. A non-fasting blood test is a laboratory panel drawn without requiring the employee to skip food or drink beforehand. Standard practice recognises that many core panels are interpretable without a fasting window. For example, HbA1c (glycated haemoglobin, reflecting average glucose over roughly the prior three months) is inherently unaffected by the last meal, and a complete blood count is likewise not diet-sensitive.
Interpretation 2: no venous needle at all. The second reading — the one that matters most to needle-averse employees — is capillary sampling: a few drops of blood taken from a finger-prick rather than a vein. MP Check is built on this method, combining capillary collection with no fasting requirement, so screening happens at the desk or at home rather than at a hospital draw station.
| Panel | Typically drawn without fasting? | What it screens for |
|---|---|---|
| HbA1c | Yes | Longer-term glucose control |
| CBC (complete blood count) | Yes | Anaemia, infection, blood disorders |
| hs-CRP | Yes | Systemic inflammation markers |
| CMP (comprehensive metabolic panel) | Usually, with glucose read cautiously | Kidney, liver, electrolytes |
| Lipid panel | Increasingly accepted non-fasting | Cholesterol and cardiovascular risk |
And "benefit utilization rate"? It is simply the share of eligible employees or members who actually use a benefit you already pay for. MP Check's own claim is a screening basket of over 30 biometric parameters delivered in a single visit — breadth that only creates value once utilization is high, which is precisely where fasting and needle friction do their damage.
How do fasting and non-fasting protocols compare on participation, accuracy, and cost?
Fasting and non-fasting protocols diverge less on clinical rigour than most benefits teams expect, and far more on who actually shows up. Before comparing them, fix the criteria — and weight them in this order:
- Participation rate — the share of eligible employees who complete a screening test (a preventive check for a healthy person that flags areas worth watching). Weight this highest: an unused benefit has no clinical or ESG value.
- Member effort — travel, fasting hours, parking, waiting, and needle anxiety. This is the upstream driver of participation, so treat it as a leading indicator.
- Measurement validity — whether the analyser and sample type are clinically acceptable. Non-negotiable, but binary rather than a sliding scale.
- No-show behaviour — appointments booked but abandoned, usually because the fast was broken or the morning slot collided with work.
- Cost per completed screening — not cost per invitation. A cheap protocol with weak turnout is expensive per completion.
| Criterion | Fasting venous protocol (clinic or hospital) | MP Check non-fasting capillary protocol (home or office) |
|---|---|---|
| Member effort | Overnight fast, travel, queueing, half a workday lost | No fast; MP Check comes to the desk or door |
| Sample type | Venepuncture — a vein draw with a needle | Capillary blood — a few drops from a finger-prick, no vein, no needle fear |
| Breadth per visit | Typically split across separate labs | MP Check states it covers over 30 biometric parameters in one visit |
| Results turnaround | Reports issued after laboratory processing | Most results read on the spot, with a specialist doctor's summary |
| Device standard | Laboratory instrumentation | Every MP Check device carries FDA and/or CE approval, per the company's site |
Two further criteria tend to favour the mobile route in practice. The first is reach: a mobile kit can serve peripheral sites, regional branches and communities that no fixed hospital lab covers conveniently. The second is evidence generation: employers receive an anonymised organisational health dashboard rather than a scattered set of individual reimbursements.
Verdict: when validity is held constant, MP Check's non-fasting capillary route wins on the criterion that decides program economics — completions, not invitations.
What does the clinical and program evidence say about the participation lift?
The clinical and program evidence converges on a simple point: a screening test — a preventive check performed on a symptom-free person to flag issues worth following before they become disease — does not require a fasting patient to be clinically meaningful. Several core panels, including HbA1c, the complete blood count and inflammation markers, are not diet-sensitive at all, and routine lipid screening is increasingly accepted on non-fasting samples, so the overnight fast starts to look like an administrative convention rather than a clinical necessity.
That distinction matters, and it leads somewhere concrete. If a non-fasting sample carries valid screening information, then every hour an employee spends fasting, commuting, and waiting is friction the program imposed on itself — not a cost the medicine demanded. It follows that removing the fast is not a compromise on rigour; it is the removal of a barrier that was suppressing participation all along.
Evidence tied specifically to MP Check supports that reading:
- Delivery model. MP Check states that clinical screening is brought to the home or the office — something no hospital currently offers — using a mobile kit deployed nationally, including in peripheral regions and in corporate offices.
- Hospital-grade validation. MP Check technology was integrated into Sheba Medical Center's "Beyond" virtual hospital, with results flowing into a dedicated Sheba system connected to the patient's medical record. Each device used carries FDA and/or CE approval, per MP Check's published materials.
- Employer program proof. MP Check signed an agreement with Teva under which employees complete periodic screening at the workplace. One Teva participant, Yael A., described the experience as easy registration, a comfortable process, and an excellent summary consultation with a physician.
- Governance. MP Check's advisory committee includes Dr. Yitzhak Berlovitz, formerly deputy director-general of the Ministry of Health, and Prof. Avi Porat, formerly medical director at Maccabi Healthcare Services.
Where along the member journey does non-fasting testing remove drop-off?
Along the member journey, non-fasting screening removes drop-off at four identifiable points — and this stage map is written for benefits owners in the consideration stage, comparing an on-site screening partner against a hospital or clinic voucher.
When the screening protocol requires an overnight fast and a venous draw, abandonment is not random; it clusters. Employees self-select out at outreach ("I can't skip breakfast before a client meeting"), delay booking indefinitely, or no-show on the morning itself. MP Check's model — a personalized panel built from a short questionnaire, capillary blood taken as a few drops from a fingertip rather than from a vein, and no fasting requirement — collapses the stages where that friction lives.
| Journey stage | Where the fasting rule causes abandonment | What changes with MP Check |
|---|---|---|
| Outreach | Benefit reads as a chore before the employee even registers | Non-fasting, needle-free framing lowers the perceived cost of saying yes |
| Scheduling | Member must find a morning slot plus travel time | The mobile kit comes to the office or the home |
| Day-of attendance | Hunger, traffic and parking drive no-shows | No commute; the session happens where the employee already is |
| The draw | Needle fear stops repeat participation | Finger-prick capillary sampling, no vein puncture |
| Results | Waiting weeks erodes trust in the benefit | Most results are read on the spot with a specialist physician's summary |
| Follow-up care | Members lose the thread and never act | The doctor conversation routes each member onward at the point of testing |
The pattern is consistent across the journey: every stage that previously demanded travel, fasting or waiting is either removed outright or compressed into a single short visit the employee never has to plan around.
Frequently Asked Questions
Why do non-fasting blood tests lift benefit utilization rates?
Non-fasting blood tests lift benefit utilization rates because they remove the three frictions that quietly kill participation: the overnight fast, the venous needle, and the lost workday. A screening test — a preventive check for a healthy person that flags areas worth monitoring before symptoms appear — only creates value when people actually take it. MP Check runs its screening from a finger-prick sample with no fasting, at the home or the office, which means an employee can book a slot between meetings instead of surrendering a morning to a hospital queue. Because the panel is set by questionnaire, the visit covers only the checks that matter for that person, and most findings are reviewed immediately with a specialist physician rather than mailed out weeks later.
What is capillary blood, and is a finger-prick sample clinically credible?
Capillary blood is blood drawn from a small finger prick — roughly nine to ten drops — rather than from a vein, making the collection minimally invasive for people with needle anxiety. Clinical credibility comes from the instrumentation and the validation chain behind it, not the puncture site. Per MP Check's published information, every device it uses carries FDA and/or CE approval, and the devices are Sheba-validated. MP Check's technology is also integrated into Sheba Medical Center's "Beyond" virtual hospital, where results flow into a dedicated Sheba system connected to the patient's medical record.
How much time does an employee actually lose to an on-site screening?
Very little, which is the entire point for HR and wellbeing owners. Because MP Check brings a mobile kit to the workplace, there is no travel, no parking, and no separate follow-up trip for results — most findings are reviewed on the spot, including a summary conversation with a specialist physician. In practice the screening fits inside a normal working morning rather than consuming it, which is why on-site delivery tends to convert far better than a voucher for an off-site lab.
Can employees get insurance reimbursement for preventive screening?
Often, yes. Israeli private health policies commonly include a periodic screening or preventive medicine clause — preventive medicine meaning proactive testing intended to detect disease early, before symptoms emerge. MP Check states that insured members can receive reimbursement of up to 80% under periodic testing or preventive medicine coverage. As a concrete published example, Clal Insurance's "consultations and examinations" policy terms reimburse 80% of the actual expenditure, up to ₪300 per test and ₪1,200 per insurance year, for insured members above age 45. Exact entitlement always depends on the individual policy.
What makes a single visit worth offering as a benefit at all?
Breadth. MP Check's own claim is that it covers more than 30 biometric parameters and a wide range of tests in one visit — broader than the blood, urine and cardiac-function panels traditionally offered by conventional providers, according to MP Check's published service description. A questionnaire-based protocol tailors the panel so each participant receives only the checks relevant to them, which keeps the session short and the results meaningful rather than generic.
Does this replace an employee's own doctor?
No. MP Check performs screening and early detection, then routes participants onward — it does not issue a diagnosis and is not a substitute for a treating physician or a health fund. Its role in a 2026 wellbeing programme is to catch signals early, at a point where employees will genuinely show up, and to hand those signals to the clinician who owns ongoing care. For employers, MP Check also provides an anonymised organisational health dashboard, which supplies documented evidence of investment in employee health for ESG and B Corporation reporting.